Hmmmm | DVAX Message Board Posts

Dynavax Technologies Corporation

  DVAX website

DVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1253 of 1648  at  10/6/2018 3:34:59 PM  by

fairvalueforyou


 In response to msg 1252 by  phition42
view thread

Re: Hmmmm

The street has token advantage of slower H-B vaccine sale resulting from extra 3+ month longer H-B vaccine acceptance processing time for each large customer to beat down PPS to this current ridiculous level. But that is not going to last for too long because majority of H-B vaccine customers will complete this acceptance process by the end of 2018, H-B vaccine sale revenue will kick in right from Q1 2019.
Furthermore, additional SD-101 naive Melanoma trial data will be released in 2 weeks at ESMO, AZD1419 data, and DV281 lung cancer dose escalation data  will be released before the end of 2018.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 178
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...